Xencor Launches $110M Public Offering
socalTECH
DECEMBER 1, 2016
Monrovia-based biotechnology developer Xencor has launched a public offering of its common stock, with the aim of raising approximately $110M in funding, the company said on Wednesday. The publicly traded biotechnology developer--which trades on the NASDAQ as XNCR--said it has priced the offering at $24.000 per share.
100 
Let's personalize your content